Depemokimab significantly reduces asthma exacerbations, showing similar efficacy in both controlled and uncontrolled asthma patients. The study included patients with eosinophilic asthma using medium- ...

The digital asthma self-management program significantly improved symptom control, especially for those with uncontrolled asthma, showing a 2.8-point Asthma Control Test score difference over usual ...

Please provide your email address to receive an email when new articles are posted on . Asthma control and quality-of-life scores improved over 16 weeks in a weight management program vs. usual care.

In the VOYAGE trial, dupilumab (Dupixent) significantly reduced asthma exacerbations and improved lung function and asthma control in children (ages 6 to 11 years) with uncontrolled, ...

WASHINGTON -- Adding dupilumab (Dupixent) to a medium-dose inhaled corticosteroid (ICS) routine helped lower asthma exacerbations and improved both lung function and asthma control, according to a ...

The FDA granted fast track designation to KT-621 for treating patients with moderate to severe eosinophilic asthma, according ...

The FDA has granted Fast Track designation to KT-621, a first-in-class oral STAT6 degrader for moderate to severe ...

Adult asthma affects more than 25 million Americans, yet many sufferers unknowingly engage in daily practices that exacerbate their condition. Unlike childhood asthma, which often receives immediate ...